US judge denies initial attempt by Novartis to block generic Entresto launch
The court rebuffed claims by Novartis that it would experience “irreparable harm” in the absence of an injunction following MSN’s generic roll-out.
The court rebuffed claims by Novartis that it would experience “irreparable harm” in the absence of an injunction following MSN’s generic roll-out.
What's Your Reaction?
